Roivant Sciences Ltd
ROIV
$33.49-3.18%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$7.47B
EV/Sales
732.7
P/E ratio
N/A
FY2026 Revenue
$8.26M
EPS (9mo ended 2025-12-31)
$-0.88
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
-3629.19%
Beta
1.16
Div yield
N/A
Sector
Healthcare
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 93.4% from 2024-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
Use this ROIV research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ROIV income, balance, and cash tables.
Roivant Sciences Ltd (ROIV) is a biotechnology company in the Healthcare sector.
Latest cached Roivant Sciences Ltd (ROIV) revenue for Mar 31, 2026 was $8.3M. Net income was -$299.8M. Statements: https://lician.com/financials/roiv
Roivant Sciences Ltd (ROIV) market capitalization is $7.47B on the latest cached snapshot.
Roivant Sciences Ltd (ROIV) cached previous close $34.59; day range $33.49 – $34.44; volume 1,499,932. Session quote: https://lician.com/quote/roiv
Roivant Sciences Ltd (ROIV) latest cached earnings event is "ROIV earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ROIV filing is 8-K · Sep 18, 2026. Filings: https://lician.com/sec/roiv